| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 19033011 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 1989 journal articles in the PubMed database | Email to a friend | | |
| Dudek D, Siudak Z, Janzon M, et al.
European registry on patients with ST-elevation myocardial infarction transferred for mechanical reperfusion with a special focus on early administration of abciximab -- EUROTRANSFER Registry. [Comparative Study, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't]
Am Heart J 2008 Dec; 156(6):1147-54.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Beeres SL, Oemrawsingh PV, Warda HM, et al.
Early administration of abciximab in patients with acute myocardial infarction improves angiographic and clinical outcome after primary angioplasty. [Evaluation Studies, Journal Article]
Catheter Cardiovasc Interv 2005 Aug; 65(4):478-83.
Abstract | Full Citation | Find Related Articles | | Rakowski T, Zalewski J, Legutko J, et al.
Early abciximab administration before primary percutaneous coronary intervention improves infarct-related artery patency and left ventricular function in high-risk patients with anterior wall myocardial infarction: a randomized study. [Journal Article, Randomized Controlled Trial]
Am Heart J 2007 Mar; 153(3):360-5.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Gabriel HM, Oliveira JA, da Silva PC, et al.
Early administration of abciximab bolus in the emergency department improves angiographic outcome after primary PCI as assessed by TIMI frame count: Results of the early ReoPro administration in myocardial infarction (ERAMI) trial. [JOURNAL ARTICLE]
Catheter Cardiovasc Interv 2006 Jun 30.
Abstract | Full Citation | | Thiele H, Schindler K, Friedenberger J, et al.
Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial. [Journal Article]
Circulation 2008 Jul 1; 118(1):49-57.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Shen J, Zhang Q, Zhang RY, et al.
Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. [Journal Article]
Coron Artery Dis 2008 Jun; 19(4):271-7.
Abstract | Full Citation | | Bellandi F, Maioli M, Leoncini M, et al.
Early abciximab administration in acute myocardial infarction treated with primary coronary intervention. [Journal Article]
Int J Cardiol 2006 Mar 22; 108(1):36-42.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Gurm HS, Smith DE, Collins JS, et al.
The relative safety and efficacy of abciximab and eptifibatide in patients undergoing primary percutaneous coronary intervention: insights from a large regional registry of contemporary percutaneous coronary intervention. [Comparative Study, Journal Article]
J Am Coll Cardiol 2008 Feb 5; 51(5):529-35.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Di Mario C, Dudek D, Piscione F, et al.
Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial. [Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
Lancet 2008 Feb 16; 371(9612):559-68.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
